Entyvio (vedolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** VEDOLIZUMAB

**Strength:** 300 mg/5mL

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** BLA (BLA125476)

**Pharmacologic class:** Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]